Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography
NCT ID: NCT00797524
Last Updated: 2015-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2008-11-30
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To show if it is possible to use OCT as an indirect measurement of leakage, this study will check, in a primary analysis, for OCT changes between fluorescein leaking and non-leaking areas (identified by Retinal Leakage Analyzer).
As a secondary objective, changes in RLA and OCT over time (between two consecutive visits) will be analyzed and characterized.
The results of this study will be used exclusively for scientific purposes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function
NCT00759044
Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography
NCT01220804
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Dual Wavelength OCT
NCT03843840
OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration)
NCT03939195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DR
Diabetic Retinopathy
No interventions assigned to this group
ARMD
Age-Related Macular Degeneration
No interventions assigned to this group
ME
Macular Edema
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females or Males
* Age over 18 years
* Signed Informed Consent Form
Exclusion Criteria
* Vitreous syneresis or posterior vitreous detachment
* Dilatation of the pupil \< 5 mm
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association for Innovation and Biomedical Research on Light and Image
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José Cunha-Vaz, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Association for Innovation and Biomedical Research on Light and Image
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AIBILI
Coimbra, Coimbra District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bernardes R, Maduro C, Serranho P, Araujo A, Barbeiro S, Cunha-Vaz J. Improved adaptive complex diffusion despeckling filter. Opt Express. 2010 Nov 8;18(23):24048-59. doi: 10.1364/OE.18.024048.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
023RLAOCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.